Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-202 for central abdominal bulging (AbCONTOUR2)
NCT02398188Phase 3Completed
- Sponsor
- Evofem Biosciences, Inc.
- Start
- Apr 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol, sponsored by Evofem Biosciences, Inc.. Started Apr 2015; status: completed.
02
Drugs
salmeterol
Beyond the preview
Go deeper on NCT02398188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02398188.